Intas Pharmaceuticals Limited Paclitaxel Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Paclitaxel Export Records India — #3 Exporter, 405 Shipments, $5.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Paclitaxel

India Pharmaceutical Trade Intelligence

$83.1M319 Suppliers142 CountriesHS 30049044

ExportsIndia → GERMANY20.6%India → UNITED STATES13.1%

ImportsSOUTH KOREA → India$1.6B UNITED STATES → India$2.3M

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Intas Pharmaceuticals Limited — Paclitaxel Exporter #3 | $5.9M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Paclitaxel Exporter Profile

Indian Pharmaceutical Exporter · #3 for Paclitaxel · $5.9M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Paclitaxel with $5.9M in export value and 405 verified shipments. Intas Pharmaceuticals Limited holds a 7.1% market share in Paclitaxel exports across 19 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Paclitaxel Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Paclitaxel export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Paclitaxel?

Country	Value	Shipments	Share
BRAZIL	$2.2M	68	40.0%
CANADA	$567.9K	21	10.5%
UNITED KINGDOM	$453.7K	18	8.4%
NETHERLANDS	$453.5K	47	8.4%
MEXICO

Who Are the Top Buyers of Paclitaxel from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ACCORD FARMACUTICA LTDA.	BRAZIL	$968.2K	29
ACCORD FARMACUTICA LTDA	BRAZIL	$519.5K	19
ACCORD FARMACUTICA LIMITEDA	BRAZIL	$503.1K	16
ACCORD UK	UNITED KINGDOM	$384.6K	11
ACCORD FARMA S A DE C V	MEXICO	$339.1K	9
XXCORXXHEAXXHCAXX B XX	FRANCE	$300.0K	6
ACCORD HEALTHCARE INC.	CANADA	$267.8K	9
ACCORD HEALTHCARE INC	CANADA	$175.3K	7
TO THE ORDER	ITALY	$141.1K	34
BROCACEF NL : DUTCH	NETHERLANDS	$136.5K	10

Intas Pharmaceuticals Limited supplies Paclitaxel to 63 buyers globally. The largest buyer is ACCORD FARMACUTICA LTDA. (BRAZIL), followed by ACCORD FARMACUTICA LTDA (BRAZIL) and ACCORD FARMACUTICA LIMITEDA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Paclitaxel Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI PACLITAXEL INJ USP 6	$838.8K	27
PHARMACEUTICAL DRUGS AND MEDICINE :ACOEXCEL 300MG/50ML INJ. 1X1 VIAL E1 EACH ML CONTAINS PACLITAXEL USP...6.00MG ETHAN	$221.2K	6
PHARMA DRUGS & MEDI PACLITAXEL INJ USP 6MG/ML, 16.7ML VIAL AS PER INVOICEVLS	$181.0K	6
PHARMA DRUGS AND MEDI PACLITAXEL INJ USP	$153.8K	5
PACLITAXEL 6MG/ML 100ML P1ACO-FRANCE	$150.7K	6
PHARMA DRUGS & MEDI PACLITAXEL INJ,6MG/M	$141.1K	3
PHARMA DRUGS AND MEDI PACLITAXEL INJ USP6MG/ML, 50ML VIAL AS PER INVVLS	$140.1K	4
PHARMA DRUGS AND MEDI PACLITAXEL INJ USP6MG/ML, 50ML VIAL AS PER INV	$115.0K	5
PHARMA DRUG&MED:PACLITAXEL INJ USP 6MG/M	$105.4K	5
PACLITAXEL 6MG/ML 100ML P1(ACO-FRANCE	$100.3K	4

Intas Pharmaceuticals Limited exports 241 distinct Paclitaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI PACLITAXEL INJ USP 6 with 27 shipments worth $838.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Paclitaxel Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	FRESENIUS KABI ONCOLOGY LIMITED	$25.1M	854	24	$29.4K
2	MSN LABORATORIES PRIVATE LIMITED	$6.9M	138	2	$50.0K
3	INTAS PHARMACEUTICALS LIMITED ★	$5.9M	405	19	$14.7K
5	PANACEA BIOTEC PHARMA LIMITED	$3.3M	65	15	$50.0K
6	VENUS REMEDIES LIMITED	$3.2M	220	18	$14.4K

Intas Pharmaceuticals Limited ranks #3 among 319 Indian Paclitaxel exporters. Average shipment value of $14.7K compared to the market average of $192.6K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and MSN LABORATORIES PRIVATE LIMITED.

Which Indian Ports Ship Paclitaxel Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	830	16.8%
SAHAR AIR	614	12.5%
DELHI AIR	599	12.2%
SAHAR AIR CARGO ACC (INBOM4)	554	11.2%
HYDERABAD AIR	186	3.8%
AHEMDABAD AIR	183	3.7%
Bombay Air	172	3.5%
HYDERABAD ACC (INHYD4)	160	3.2%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Paclitaxel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 424 individual customs records matching Intas Pharmaceuticals Limited exporting Paclitaxel, covering 241 formulations to 19 countries via 63 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 142+ countries, 959+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Paclitaxel

Paclitaxel

Intas Pharmaceuticals Limited — Paclitaxel Exporter Profile

Intas Pharmaceuticals Limited — Paclitaxel Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Paclitaxel?

Who Are the Top Buyers of Paclitaxel from Intas Pharmaceuticals Limited?

What Is India's Total Paclitaxel Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Paclitaxel Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Paclitaxel Exporters?

What Paclitaxel Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Paclitaxel to Key Markets

Brazil — ANVISA

Canada — HC

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Paclitaxel Exporters?

Which Indian Ports Ship Paclitaxel Exports?

What Other Oncology Products Does Intas Pharmaceuticals Limited Export?

Paclitaxel — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Paclitaxel Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Paclitaxel Export Data from Intas Pharmaceuticals Limited

Paclitaxel Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source